ZoomInfo (ZI) Explodes on Strong Q2 Results and Guidance, Analysts Bulled Up with 10 PT Hikes
- S&P 500 ends higher as markets weigh rising yields, upbeat corporate results
- Meta Platforms reports softer Q2 revenue guidance on plans to boost spending on AI
- IBM (IBM) announces mixed Q1 results, HashiCorp acquisition; shares down
- Equities mixed as investors eye earnings; yen on intervention watch
- ServiceNow (NOW) stock falls as refreshed subscription outlook trails estimates
- Fisker (FSR) Appoints Michael Healy as Chief Restructuring Officer
- Seagate Technology (STX) Enters $600M Asset Purchase Agreement with Avago
- Meta Platforms (META) Tops Q1 EPS by 39c, Offers Guidance
- Hasbro (HAS) brand strength sees earnings top expectations
- IBM (IBM) announces mixed Q1 results, HashiCorp acquisition; shares down
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
- Midday movers: PepsiCo, JetBlue fall; GM, Danaher and UPS rise
- After-hours movers: Cadence Design Systems, Cleveland-Cliffs, Riot Platforms, and more
ZoomInfo Technologies Inc. (ZI) Upsizes Secondary Offering to 27M Shares from 20M Shares
August 4, 2021 5:33 AM EDTZoomInfo Technologies Inc. (NASDAQ: ZI) today announced an upsizing of the previously announced underwritten secondary offering by certain selling stockholders of ZoomInfo, including investment funds affiliated with TA Associates (TA), The Carlyle Group (Carlyle) and 22C Capital LLC (22C Capital) and an entity affiliated with ZoomInfos co-founders (together with TA, Carlyle and 22C Capital, the Selling Stockholders), to 27,000,000 shares of ZoomInfos Class A common stock pursuant to ZoomInfos... More
ZoomInfo Technologies (ZI) PT Raised to $70 at Stifel
August 3, 2021 9:30 AM EDTStifel analyst Parker Lane raised the price target on ZoomInfo Technologies (NASDAQ: ZI) to $70.00 (from $65.00) while maintaining a Buy rating.... More
Pre-Open Stock Movers 08/03: (OTLK) (TBIO) (HOLI) Higher; (CLX) (RNA) (KOPN) Lower (more...)
August 3, 2021 9:22 AM EDTPre-Open Stock Movers:
Outlook Therapeutics, Inc. (Nasdaq: OTLK) 34.5% HIGHER; announced positive clinical and highly statistically significant top-line results from its pivotal Phase 3 NORSE TWO safety and efficacy trial evaluating ONS-5010 / LYTENAVA (bevacizumab) for treatment of neovascular age-related macular degeneration (wet AMD). Outlook Therapeutics will host a conference call and webcast today, August 3, 2021, at 8:00 a.m. ET (details below) to discuss the results of the study.
Translate Bio (NASDAQ: TBIO) 29.2% HIGHER; As part of Sanofis endeavor to... More
ZoomInfo Technologies (ZI) PT Raised to $80 at Morgan Stanley
August 3, 2021 8:45 AM EDTMorgan Stanley analyst Stan Zlotsky raised the price target on ZoomInfo Technologies (NASDAQ: ZI) to $80.00 (from $75.00) while maintaining a Overweight rating and seeing a 4:1 bull/bear risk/reward skew. The company reported accelerating growth momentum in Q2 across organic revenue, billings and cRPO bookings. Cash... More
ZoomInfo Technologies (ZI) PT Raised to $70 at Canaccord Genuity
August 3, 2021 8:43 AM EDTCanaccord Genuity analyst David Hynes Jr. raised the price target on ZoomInfo Technologies (NASDAQ: ZI) to $70.00 (from $65.00) while maintaining a Buy rating.... More
ZoomInfo Technologies (ZI) PT Raised to $75 at BofA Securities
August 3, 2021 8:16 AM EDTBofA Securities analyst Brad Sills raised the price target on ZoomInfo Technologies (NASDAQ: ZI) to $75.00 (from $70.00) while maintaining a Buy rating.
... MoreZoomInfo Technologies (ZI) PT Raised to $70 at Raymond James
August 3, 2021 7:17 AM EDTRaymond James analyst Brian Peterson raised the price target on ZoomInfo Technologies (NASDAQ: ZI) to $70.00 (from $62.00) while maintaining a Outperform rating.... More
ZoomInfo Technologies (ZI) PT Raised to $80 at Truist Securities
August 3, 2021 7:13 AM EDTTruist Securities raised its price target on ZoomInfo Technologies (NASDAQ: ZI) to $80.00 (from $70.00) while maintaining a Buy rating.... More
ZoomInfo Technologies (ZI) PT Raised to $60 at Deutsche Bank
August 3, 2021 6:40 AM EDTDeutsche Bank analyst Taylor McGinnis raised the price target on ZoomInfo Technologies (NASDAQ: ZI) to $60.00 (from $54.00) while maintaining a Hold rating.... More
ZoomInfo Technologies (ZI) PT Raised to $70 at Mizuho Securities
August 3, 2021 6:34 AM EDTMizuho Securities analyst Siti Panigrahi raised the price target on ZoomInfo Technologies (NASDAQ: ZI) to $70.00 (from $63.00) while maintaining a Buy rating.... More
ZoomInfo Technologies (ZI) PT Raised to $76 at Wells Fargo
August 3, 2021 6:34 AM EDTWells Fargo analyst Michael Turrin raised the price target on ZoomInfo Technologies (NASDAQ: ZI) to $76.00 (from $64.00) while maintaining a Overweight rating.... More
ZoomInfo Technologies (ZI) PT Raised to $66 at Barclays
August 3, 2021 4:16 AM EDTBarclays analyst Raimo Lenschow raised the price target on ZoomInfo Technologies (NASDAQ: ZI) to $66.00 (from $59.00) while maintaining a Equalweight rating.... More
UPDATE: RBC Capital Assumes ZoomInfo Technologies (ZI) at Outperform
August 3, 2021 1:30 AM EDT(Updated - August 3, 2021 4:29 AM EDT)
RBC Capital analyst Rishi Jaluria assumes coverage on ZoomInfo Technologies (NASDAQ: ZI) with a Outperform rating and a price target of $70.00 (from $60.00).
The analyst comments "ZI posted a strong beat-and-raise quarter with full year guidance... More
ZoomInfo Technologies Inc. (ZI) Tops Q2 EPS by 2c, Raises Guidance
August 2, 2021 4:10 PM EDTZoomInfo Technologies Inc. (NASDAQ: ZI) reported Q2 EPS of $0.14, $0.02 better than the analyst estimate of $0.12. Revenue for the quarter came in at $174 million versus the consensus estimate of $162.34 million.
GUIDANCE:
ZoomInfo Technologies Inc. sees Q3 2021 EPS of $0.11-$0.12, versus the consensus... More